Morgan Stanley
NARI

Morgan Stanley’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Morgan Stanley’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,150,771
Closed -$110M – 8296
2024
Q4 		$110M Buy
2,150,771
+989,513
+85% +$48.6M 0.01% 1182
2024
Q3 		$47.9M Buy
1,161,258
+40,519
+4% +$1.95M ﹤0.01% 1860
2024
Q2 		$54M Sell
1,120,739
-452,935
-29% -$20.1M ﹤0.01% 1696
2024
Q1 		$75.5M Buy
1,573,674
+786,692
+100% +$42M 0.01% 1388
2023
Q4 		$51.1M Sell
786,982
-117,467
-13% -$7.07M ﹤0.01% 1703
2023
Q3 		$59.2M Sell
904,449
-89,742
-9% -$5.65M 0.01% 1421
2023
Q2 		$57.8M Sell
994,191
-128,048
-11% -$8.08M 0.01% 1460
2023
Q1 		$69.3M Sell
1,122,239
-151,391
-12% -$9.08M 0.01% 1289
2022
Q4 		$81M Buy
1,273,630
+1,019,378
+401% +$73.9M 0.01% 1171
2022
Q3 		$18.5M Sell
254,252
-13,365
-5% -$995K ﹤0.01% 2273
2022
Q2 		$18.2M Buy
267,617
+80,288
+43% +$5.77M ﹤0.01% 2398
2022
Q1 		$17M Buy
187,329
+68,781
+58% +$5.63M ﹤0.01% 2293
2021
Q4 		$10.8M Sell
118,548
-57,772
-33% -$4.95M ﹤0.01% 2869
2021
Q3 		$14.3M Sell
176,320
-1,824
-1% -$153K ﹤0.01% 2478
2021
Q2 		$16.6M Buy
178,144
+82,802
+87% +$8.03M ﹤0.01% 2368
2021
Q1 		$10.2M Sell
95,342
-279,977
-75% -$29M ﹤0.01% 2625
2020
Q4 		$32.8M Buy
375,319
+343,952
+1,097% +$24.3M 0.01% 1412
2020
Q3 		$2.17M Buy
31,367
+23,536
+301% +$1.51M ﹤0.01% 3587
2020
Q2 		$380K Buy
+7,831
New +$374K ﹤0.01% 4746

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Morgan Stanley's NARI Position: Q1 2025 in Review

Morgan Stanley sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 2,150,771 shares — an estimated $110M sold.

Morgan Stanley first reported a position in NARI in Q2 2020 and held it in 19 quarters. The position peaked at $110M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Morgan Stanley reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Morgan Stanley sold 2,150,771 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $110M.
  • Morgan Stanley first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 19 quarters.
  • Morgan Stanley's Inari Medical, Inc. Common Stock position peaked at $110M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.